SORIA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 4.715
AS - Asia 2.773
EU - Europa 2.384
SA - Sud America 476
AF - Africa 77
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 10.437
Nazione #
US - Stati Uniti d'America 4.453
SG - Singapore 957
IT - Italia 554
CN - Cina 487
VN - Vietnam 437
HK - Hong Kong 385
BR - Brasile 358
DE - Germania 355
RU - Federazione Russa 335
SE - Svezia 281
CA - Canada 210
IE - Irlanda 205
FR - Francia 159
GB - Regno Unito 143
IN - India 100
UA - Ucraina 68
BD - Bangladesh 61
ID - Indonesia 51
IQ - Iraq 48
AT - Austria 47
TR - Turchia 43
FI - Finlandia 42
AR - Argentina 36
NL - Olanda 33
JP - Giappone 32
DK - Danimarca 30
MX - Messico 30
ES - Italia 28
PL - Polonia 28
CO - Colombia 26
ZA - Sudafrica 26
PK - Pakistan 22
KR - Corea 19
SA - Arabia Saudita 19
PH - Filippine 17
EC - Ecuador 16
BE - Belgio 13
UZ - Uzbekistan 12
KE - Kenya 11
VE - Venezuela 11
CH - Svizzera 10
CL - Cile 10
AE - Emirati Arabi Uniti 9
IR - Iran 9
MY - Malesia 9
CZ - Repubblica Ceca 8
LT - Lituania 8
OM - Oman 8
DZ - Algeria 7
MA - Marocco 7
BG - Bulgaria 6
GR - Grecia 6
PE - Perù 6
PY - Paraguay 6
SN - Senegal 6
EG - Egitto 5
IL - Israele 5
JM - Giamaica 5
JO - Giordania 5
AU - Australia 4
EU - Europa 4
LB - Libano 4
NP - Nepal 4
PA - Panama 4
PT - Portogallo 4
RO - Romania 4
TH - Thailandia 4
TN - Tunisia 4
UY - Uruguay 4
AZ - Azerbaigian 3
ET - Etiopia 3
HN - Honduras 3
HR - Croazia 3
HU - Ungheria 3
KZ - Kazakistan 3
MD - Moldavia 3
SY - Repubblica araba siriana 3
TT - Trinidad e Tobago 3
AL - Albania 2
AM - Armenia 2
BH - Bahrain 2
BO - Bolivia 2
BY - Bielorussia 2
CR - Costa Rica 2
GE - Georgia 2
KG - Kirghizistan 2
LY - Libia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PR - Porto Rico 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BN - Brunei Darussalam 1
BT - Bhutan 1
CI - Costa d'Avorio 1
EE - Estonia 1
KH - Cambogia 1
KN - Saint Kitts e Nevis 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 10.425
Città #
Ann Arbor 894
Singapore 543
Ashburn 390
Hong Kong 375
San Jose 318
Frankfurt am Main 257
Chandler 244
Fairfield 225
Dublin 200
New York 173
Wilmington 150
Toronto 149
Ho Chi Minh City 121
Hanoi 116
Houston 115
Woodbridge 111
Milan 107
Los Angeles 106
Beijing 92
Seattle 89
Chicago 88
Paris 83
Santa Clara 82
Dallas 81
Cambridge 70
Princeton 70
The Dalles 50
Jacksonville 49
Hefei 46
Jakarta 43
Buffalo 41
Lauterbourg 38
Altamura 37
Dearborn 36
Council Bluffs 35
Vienna 34
Moscow 33
São Paulo 33
Lawrence 32
Shanghai 31
London 26
Tokyo 26
Rome 25
Pune 23
Guangzhou 22
Baghdad 21
Haiphong 21
Orem 21
Johannesburg 20
Nanjing 20
Warsaw 20
Boardman 19
Denver 19
Montreal 19
Nuremberg 19
Seoul 19
Poplar 18
Andover 17
Fremont 17
Helsinki 17
Stockholm 17
Bogotá 15
Boston 15
Munich 15
Phoenix 15
Amsterdam 14
Brooklyn 14
Dong Ket 14
Lappeenranta 13
Ottawa 13
San Diego 13
Bologna 12
Brussels 12
Da Nang 11
Nairobi 11
Rio de Janeiro 11
Salt Lake City 11
Tashkent 11
Changsha 10
Manchester 10
Thái Nguyên 10
Atlanta 9
Chennai 9
Hangzhou 9
Hải Dương 9
Jeddah 9
Lachine 9
Quận Bình Thạnh 9
Biên Hòa 8
Catania 8
Columbus 8
Falls Church 8
Mexico City 8
Shenyang 8
Washington 8
Barnet 7
Busto Arsizio 7
Dhaka 7
Guarulhos 7
Hebei 7
Totale 6.617
Nome #
Feasibility and physiological effects of prone positioning in non-intubated patients with acute respiratory failure due to COVID-19 (PRON-COVID): a prospective cohort study 522
Remdesivir use in patients requiring mechanical ventilation due to COVID-19 393
Helmet CPAP to treat hypoxic pneumonia outside the ICU: an observational study during the COVID-19 outbreak 365
Similar success rates but lower incidence of telaprevir-related rash in HIV/HCV coinfected as compared to HCV-monoinfected patients treated with triple anti-HCV therapy 350
Caratteristiche di una coorte di pazienti con co-infezione HIV/HCV: i dati dell’Ambulatorio di Malattie Infettive dell’Ospedale San Gerardo di Monza 338
Comparison of three therapeutic regimens for genotype-3 hepatitis C virus infection in a large real-life multicentre cohort 323
The high volume of patients admitted during the SARS-CoV-2 pandemic has an independent harmful impact on in-hospital mortality from COVID-19 323
A case of cerebrospinal fluid viral escape on a dual antiretroviral regimen: Worth the risk? 318
HIV testing: A must for patients with inflammatory bowel disease 313
HPV 16 and 18 contribute to development of anal dysplasia in HIV infection irrespective of gender and sexual orientation 310
Remission of low-grade lymphomatoid granulomatosis with extensive pulmonary involvement following immune restoration via antiretroviral therapy in a newly diagnosed HIV patient 308
Risk of chronic kidney disease among patients developing mild renal impairment during tenofovir-containing antiretroviral treatment 301
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 301
High rates of 30-day mortality in patients with cirrhosis and COVID-19 298
Prospective immune dynamics during the first 24 weeks of efavirenz based-antiretroviral therapy in HIV-1-infected subjects, according to CD4+ T-cell counts at presentation: The IMMUNEF clinical trial 294
Evaluation of adhesion molecules and immune parameters in HIV-infected patients treated with an atazanavir/ritonavir- compared with a lopinavir/ritonavir-based regimen 273
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 262
Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests 261
Malassorbimento intestinale della terapia antiretrovirale in un paziente affetto da AIDS e micobatteriosi atipica disseminata 261
Lung cryptococcosis in a treated HIV-1-infected patient with suppressed viral load and past disseminated cryptococcosis: Relapse or late IRIS? 246
Unmasking tuberculosis in the era of antiretroviral treatment 245
Influence of efavirenz and 8-hydroxy-efavirenz plasma levels on cognition and central nervous system side effects 240
Real-life effectiveness and safety of sofosbuvir/velpatasvir/voxilaprevir in hepatitis C patients with previous DAA failure 238
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 236
KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy 233
Ruolo delle strutture ambulatoriali extra-ospedaliere per pazienti con COVID-19: l’esperienza dell’Hotspot COVID di Monza. Role of outpatient facilities for patients with COVID-19: the experience of the COVID Hotspot in Monza. 221
High rates of sustained virological response despite premature discontinuation of directly acting antivirals in HCV-infected patients treated in a real-life setting 214
Beware of biases in observational studies on anti-spike monoclonal antibodies 211
Real-world effectiveness and safety of glecaprevir/pibrentasvir in 723 patients with chronic hepatitis C 207
Behavioural survey and street-based HIV and HCV rapid testing programme among transgender sex workers 207
COVID-19 Mortality and Stress to the Hospital System From High Patient Load 206
Knowledge, Use, and Misuse of Self-Prescribed Doxycycline Postexposure Prophylaxis in a Community-Based Preexposure Prophylaxis Service 203
COVID-19 Infection among Incarcerated Individuals and Prison Staff in Lombardy, Italy, March 2020 to February 2021 187
Do we Still Need Eligibility Criteria to Recommend PrEP? Impact of National Prescribing Requirements on Retention in Care and Sexually Transmitted Infections Acquisition 176
Imported ciprofloxacin-resistant Neisseria meningitidis 168
Unmasked tuberculosis or lymphoma in late AIDS presenters: A difficult differential diagnosis 167
Reply to: Correspondence on “High rates of 30-day mortality in patients with cirrhosis and COVID-19” 164
Dysmetabolism, Diabetes and Clinical Outcomes in Patients Cured of Chronic Hepatitis C: A Real-Life Cohort Study 155
Pharmacotherapy of HIV: Focus on Etravirine 140
Unexpected viral relapses in hepatitis C virus–infected patients diagnosed with hepatocellular carcinoma during treatment with direct-acting antivirals 113
Monotherapy with lopinavir/ritonavir versus standard of care in HIV-infected patients virologically suppressed while on treatment with protease inhibitor-based regimens: results from the MoLo study 108
Safety and efficacy of daclatasvir at doses other than 60 mg daily in HIV/HCV co-infected subjects: Data from the ICONA/HepaICONA foundation cohorts 98
Comparable 5-Year Survival in People With and Without HIV Following Hepatocellular Carcinoma Diagnosis: A Multicenter Study 90
Reply 64
Reply 62
Occupational HIV infection in a research laboratory with unknown mode of transmission: a case report 3
Totale 10.716
Categoria #
all - tutte 34.768
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.768


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021118 0 0 0 0 0 0 0 0 0 0 0 118
2021/2022777 89 95 125 80 33 73 8 33 18 59 60 104
2022/20231.042 107 310 106 97 52 151 17 74 63 9 38 18
2023/2024711 26 18 30 24 100 222 126 34 36 19 8 68
2024/20251.995 84 189 128 79 155 92 141 66 154 258 140 509
2025/20264.139 503 204 318 498 545 226 647 171 292 386 269 80
Totale 10.716